Cost-utility analysis of reslizumab for patients with severe eosinophilic asthma inadequately controlled with high-dose inhaled corticosteroids and long-acting β2-agonists in South Korea

Sola Han,Siin Kim,Hyungtae Kim,Hae Sun Suh

Cost-utility analysis of reslizumab for patients with severe eosinophilic asthma inadequately controlled with high-dose inhaled corticosteroids and long-acting β2-agonists in South Korea

2019

Sola Han
Siin Kim
Hyungtae Kim
Hae Sun Suh

AbstractObjectives: We aimed to assess the cost-utility of reslizumab for patients with severe eosinophilic asthma uncontrolled with high-dose inhaled corticosteroids and long-acting β2-agonists (I...

Keywords:

Anesthesia
Cost–utility analysis
Eosinophilic asthma
Pediatrics
Diabetes mellitus
Medicine
Reslizumab
long acting
inhaled corticosteroids
Asthma
Intensive care medicine
Cost-effectiveness analysis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations